KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Bristol Myers Squibb (BMY) Cost of Revenue (2016 - 2025)

Historic Cost of Revenue for Bristol Myers Squibb (BMY) over the last 17 years, with Q4 2025 value amounting to $4.1 billion.

  • Bristol Myers Squibb's Cost of Revenue fell 1485.87% to $4.1 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $13.9 billion, marking a year-over-year decrease of 22.19%. This contributed to the annual value of $13.9 billion for FY2025, which is 22.91% down from last year.
  • Latest data reveals that Bristol Myers Squibb reported Cost of Revenue of $4.1 billion as of Q4 2025, which was down 1485.87% from $3.4 billion recorded in Q3 2025.
  • Bristol Myers Squibb's 5-year Cost of Revenue high stood at $4.8 billion for Q4 2024, and its period low was $2.3 billion during Q3 2021.
  • Moreover, its 5-year median value for Cost of Revenue was $2.8 billion (2021), whereas its average is $2.9 billion.
  • As far as peak fluctuations go, Bristol Myers Squibb's Cost of Revenue crashed by 2241.94% in 2021, and later soared by 7530.05% in 2024.
  • Over the past 5 years, Bristol Myers Squibb's Cost of Revenue (Quarter) stood at $2.4 billion in 2021, then grew by 10.06% to $2.6 billion in 2022, then grew by 5.86% to $2.7 billion in 2023, then soared by 75.3% to $4.8 billion in 2024, then dropped by 14.86% to $4.1 billion in 2025.
  • Its last three reported values are $4.1 billion in Q4 2025, $3.4 billion for Q3 2025, and $3.4 billion during Q2 2025.